XML 58 R46.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 3 - Allocation of Consideration Transferred (Details) - Protagenic Therapeutics Inc [Member]
Feb. 12, 2016
USD ($)
Total value of shares issued to Atrinsic on Merger date $ 404,169
Goodwill 404,169
Net value of consideration 0
Common Stock [Member]  
Atrinsic 25,867 shares Common stock 32,334
Preferred Stock [Member] | Series B Preferred Stock [Member]  
Atrinsic 25,867 shares Common stock $ 371,835